Skip to main content
. 2020 Jun 8;4(3):e401. doi: 10.1097/HS9.0000000000000401

Figure 2.

Figure 2

Response characteristics among all patients and treatment outcomes. (A) Response characteristics and outcomes in all patients. (B) Overall survival for the whole patient group. Values are medians and 95% CIs at 25 months. (C) Progression-free survival (PFS) in whole patient group. Values are medians and 95% CIs at 25 months. (D) Duration of response (PFS) in all patients. Values are medians and 95% CIs at 25 months.